Bispecific antibody affords complete post-exposure protection of mice from both Ebola (Zaire) and Sudan viruses

Julia C. Frei, Elisabeth K. Nyakatura, Samantha E. Zak, Russell R. Bakken, Kartik Chandran, John M. Dye, Jonathan R. Lai

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Filoviruses (Ebola and Marburg) cause severe hemorrhagic fever. There are five species of ebolavirus; among these, the Ebola (Zaire) and Sudan viruses (EBOV and SUDV, respectively) are highly pathogenic and have both caused recurring, large outbreaks. However, the EBOV and SUDV glycoprotein (GP) sequences are 45% divergent and thus antigenically distinct. Few antibodies with cross-neutralizing properties have been described to date. We used antibody engineering to develop novel bispecific antibodies (Bis-mAbs) that are cross-reactive toward base epitopes on GP from EBOV and SUDV. These Bis-mAbs exhibit potent neutralization against EBOV and SUDV GP pseudotyped viruses as well as authentic pathogens, and confer a high degree (in one case 100%) post-exposure protection of mice from both viruses. Our studies show that a single agent that targets the GP base epitopes is sufficient for protection in mice; such agents could be included in panfilovirus therapeutic antibody cocktails.

Original languageEnglish (US)
Article number19193
JournalScientific Reports
Volume6
DOIs
StatePublished - Jan 13 2016

Fingerprint

Ebolavirus
Bispecific Antibodies
Glycoproteins
Antibodies
Epitopes
Viruses
Disease Outbreaks
Fever

ASJC Scopus subject areas

  • General

Cite this

Bispecific antibody affords complete post-exposure protection of mice from both Ebola (Zaire) and Sudan viruses. / Frei, Julia C.; Nyakatura, Elisabeth K.; Zak, Samantha E.; Bakken, Russell R.; Chandran, Kartik; Dye, John M.; Lai, Jonathan R.

In: Scientific Reports, Vol. 6, 19193, 13.01.2016.

Research output: Contribution to journalArticle

@article{6fc89784a066418f89e5e639575db4a5,
title = "Bispecific antibody affords complete post-exposure protection of mice from both Ebola (Zaire) and Sudan viruses",
abstract = "Filoviruses (Ebola and Marburg) cause severe hemorrhagic fever. There are five species of ebolavirus; among these, the Ebola (Zaire) and Sudan viruses (EBOV and SUDV, respectively) are highly pathogenic and have both caused recurring, large outbreaks. However, the EBOV and SUDV glycoprotein (GP) sequences are 45{\%} divergent and thus antigenically distinct. Few antibodies with cross-neutralizing properties have been described to date. We used antibody engineering to develop novel bispecific antibodies (Bis-mAbs) that are cross-reactive toward base epitopes on GP from EBOV and SUDV. These Bis-mAbs exhibit potent neutralization against EBOV and SUDV GP pseudotyped viruses as well as authentic pathogens, and confer a high degree (in one case 100{\%}) post-exposure protection of mice from both viruses. Our studies show that a single agent that targets the GP base epitopes is sufficient for protection in mice; such agents could be included in panfilovirus therapeutic antibody cocktails.",
author = "Frei, {Julia C.} and Nyakatura, {Elisabeth K.} and Zak, {Samantha E.} and Bakken, {Russell R.} and Kartik Chandran and Dye, {John M.} and Lai, {Jonathan R.}",
year = "2016",
month = "1",
day = "13",
doi = "10.1038/srep19193",
language = "English (US)",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Bispecific antibody affords complete post-exposure protection of mice from both Ebola (Zaire) and Sudan viruses

AU - Frei, Julia C.

AU - Nyakatura, Elisabeth K.

AU - Zak, Samantha E.

AU - Bakken, Russell R.

AU - Chandran, Kartik

AU - Dye, John M.

AU - Lai, Jonathan R.

PY - 2016/1/13

Y1 - 2016/1/13

N2 - Filoviruses (Ebola and Marburg) cause severe hemorrhagic fever. There are five species of ebolavirus; among these, the Ebola (Zaire) and Sudan viruses (EBOV and SUDV, respectively) are highly pathogenic and have both caused recurring, large outbreaks. However, the EBOV and SUDV glycoprotein (GP) sequences are 45% divergent and thus antigenically distinct. Few antibodies with cross-neutralizing properties have been described to date. We used antibody engineering to develop novel bispecific antibodies (Bis-mAbs) that are cross-reactive toward base epitopes on GP from EBOV and SUDV. These Bis-mAbs exhibit potent neutralization against EBOV and SUDV GP pseudotyped viruses as well as authentic pathogens, and confer a high degree (in one case 100%) post-exposure protection of mice from both viruses. Our studies show that a single agent that targets the GP base epitopes is sufficient for protection in mice; such agents could be included in panfilovirus therapeutic antibody cocktails.

AB - Filoviruses (Ebola and Marburg) cause severe hemorrhagic fever. There are five species of ebolavirus; among these, the Ebola (Zaire) and Sudan viruses (EBOV and SUDV, respectively) are highly pathogenic and have both caused recurring, large outbreaks. However, the EBOV and SUDV glycoprotein (GP) sequences are 45% divergent and thus antigenically distinct. Few antibodies with cross-neutralizing properties have been described to date. We used antibody engineering to develop novel bispecific antibodies (Bis-mAbs) that are cross-reactive toward base epitopes on GP from EBOV and SUDV. These Bis-mAbs exhibit potent neutralization against EBOV and SUDV GP pseudotyped viruses as well as authentic pathogens, and confer a high degree (in one case 100%) post-exposure protection of mice from both viruses. Our studies show that a single agent that targets the GP base epitopes is sufficient for protection in mice; such agents could be included in panfilovirus therapeutic antibody cocktails.

UR - http://www.scopus.com/inward/record.url?scp=84955112946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955112946&partnerID=8YFLogxK

U2 - 10.1038/srep19193

DO - 10.1038/srep19193

M3 - Article

C2 - 26758505

AN - SCOPUS:84955112946

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 19193

ER -